Esthesioneuroblastoma: Multimodal management and review of literature  

作　　者：Ritesh Kumar 

机构地区：[1]Department of Radiotherapy,BRAIRCH,All India Institute of Medical Sciences

出　　处：《World Journal of Clinical Cases》2015年第9期774-778,共5页世界临床病例杂志

摘　　要：Esthesioneuroblastoma(ENB) is a rare malignant neoplasm arising from the olfactory neuroepithelium. ENB constitutes only 3% of all malignant intranasal neoplasm. Because of the rarity, the number of patients of ENB treated in individual departments is small. Most of these patients presents in locally advanced stages and require multimodality treatment in form of surgery, chemotherapy and radiotherapy. Multimodality approach with a risk-adapted strategy is required to achieve good control rates while minimizing treatment related toxicity.Esthesioneuroblastoma(ENB) is a rare malignant neoplasm arising from the olfactory neuroepithelium. ENB constitutes only 3% of all malignant intranasal neoplasm. Because of the rarity, the number of patients of ENB treated in individual departments is small. Most of these patients presents in locally advanced stages and require multimodality treatment in form of surgery, chemotherapy and radiotherapy. Multimodality approach with a risk-adapted strategy is required to achieve good control rates while minimizing treatment related toxicity.

关 键 词：SURGERY RADIOTHERAPY CHEMOTHERAPY ESTHESIONEUROBLASTOMA 

分 类 号：R739.4[医药卫生—肿瘤]